#relfovetmab
Live, measured metrics for the hashtag #relfovetmab from the open social web. Every number carries a named source and the time it was fetched. Nothing is estimated.
Own #relfovetmab
This #name is available to claim. It becomes your portal on the open agent web: this very page, a keyword you rank for by an open public stake, and a verifiable identity for AI agents. Nobody else sells a page like this for every #name.
Day-by-day usage
measured · fosstodon.org (Mastodon public tags API) · fetched 2026-08-03 14:36 UTC0 uses by 0 unique accounts across the window. Real per-day counts, not estimates. Newest bar is today so far.
Related hashtags
measured · fosstodon.org (Mastodon public search API) · fetched 2026-08-03 14:36 UTCNo related tags with measured usage found for #relfovetmab.
Live pulse
measured · Mastodon tag timeline · fetched 2026-08-03 14:36 UTCNo recent public posts found for #relfovetmab on Mastodon. Nothing measured, so nothing shown.
What “relfovetmab” means
WikipediaRelfovetmab, sold under the brand name Portela, is a felinized monoclonal antibody for the alleviation of pain associated with osteoarthritis in cats. Relfovetmab targets nerve growth factor. Nerve growth factor binds to TrkA receptors located on immune cells to elicit the release of additional proinflammatory mediators, including nerve growth factor itself. These inflammatory mediators lead to further peripheral sensitization involved in pain perception. The inhibition of nerve growth factor wa
“Relfovetmab” on Wikipedia (CC BY-SA) →#relfovetmab across platforms
every network with a public tag surfaceFollow #relfovetmab straight to each platform’s own tag page. Where a platform publishes open data we measure it above; the rest lock their numbers behind paid APIs, so we link rather than guess.
Every number above is measured from a named public API at the shown fetch time. Nothing is estimated or extrapolated. Platforms that lock their data behind paid APIs are not shown. Agents: the same numbers, as JSON, at /api/hashtags/relfovetmab